The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cannabis Drug Market Research Report 2025
Synopsis
Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana.
The global Cannabis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cannabis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Drug.
Report Scope
The Cannabis Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals
Indevus Pharmaceuticals
Pharmos
Segment by Type
Oral Spray
Capsule
Tablets
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana.
The global Cannabis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cannabis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Drug.
Report Scope
The Cannabis Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals
Indevus Pharmaceuticals
Pharmos
Segment by Type
Oral Spray
Capsule
Tablets
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Spray
1.2.3 Capsule
1.2.4 Tablets
1.3 Market by Application
1.3.1 Global Cannabis Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis Drug Market Perspective (2019-2030)
2.2 Cannabis Drug Growth Trends by Region
2.2.1 Global Cannabis Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cannabis Drug Historic Market Size by Region (2019-2024)
2.2.3 Cannabis Drug Forecasted Market Size by Region (2025-2030)
2.3 Cannabis Drug Market Dynamics
2.3.1 Cannabis Drug Industry Trends
2.3.2 Cannabis Drug Market Drivers
2.3.3 Cannabis Drug Market Challenges
2.3.4 Cannabis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis Drug Players by Revenue
3.1.1 Global Top Cannabis Drug Players by Revenue (2019-2024)
3.1.2 Global Cannabis Drug Revenue Market Share by Players (2019-2024)
3.2 Global Cannabis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis Drug Revenue
3.4 Global Cannabis Drug Market Concentration Ratio
3.4.1 Global Cannabis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis Drug Revenue in 2023
3.5 Cannabis Drug Key Players Head office and Area Served
3.6 Key Players Cannabis Drug Product Solution and Service
3.7 Date of Enter into Cannabis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis Drug Breakdown Data by Type
4.1 Global Cannabis Drug Historic Market Size by Type (2019-2024)
4.2 Global Cannabis Drug Forecasted Market Size by Type (2025-2030)
5 Cannabis Drug Breakdown Data by Application
5.1 Global Cannabis Drug Historic Market Size by Application (2019-2024)
5.2 Global Cannabis Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cannabis Drug Market Size (2019-2030)
6.2 North America Cannabis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cannabis Drug Market Size by Country (2019-2024)
6.4 North America Cannabis Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabis Drug Market Size (2019-2030)
7.2 Europe Cannabis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cannabis Drug Market Size by Country (2019-2024)
7.4 Europe Cannabis Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis Drug Market Size (2019-2030)
8.2 Asia-Pacific Cannabis Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cannabis Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Cannabis Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabis Drug Market Size (2019-2030)
9.2 Latin America Cannabis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cannabis Drug Market Size by Country (2019-2024)
9.4 Latin America Cannabis Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis Drug Market Size (2019-2030)
10.2 Middle East & Africa Cannabis Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cannabis Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Cannabis Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Greenwich Biosciences
11.1.1 Greenwich Biosciences Company Detail
11.1.2 Greenwich Biosciences Business Overview
11.1.3 Greenwich Biosciences Cannabis Drug Introduction
11.1.4 Greenwich Biosciences Revenue in Cannabis Drug Business (2019-2024)
11.1.5 Greenwich Biosciences Recent Development
11.2 Abbive
11.2.1 Abbive Company Detail
11.2.2 Abbive Business Overview
11.2.3 Abbive Cannabis Drug Introduction
11.2.4 Abbive Revenue in Cannabis Drug Business (2019-2024)
11.2.5 Abbive Recent Development
11.3 Insys Therapeutics
11.3.1 Insys Therapeutics Company Detail
11.3.2 Insys Therapeutics Business Overview
11.3.3 Insys Therapeutics Cannabis Drug Introduction
11.3.4 Insys Therapeutics Revenue in Cannabis Drug Business (2019-2024)
11.3.5 Insys Therapeutics Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Detail
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Cannabis Drug Introduction
11.4.4 Bausch Health Revenue in Cannabis Drug Business (2019-2024)
11.4.5 Bausch Health Recent Development
11.5 GW Pharmaceuticals
11.5.1 GW Pharmaceuticals Company Detail
11.5.2 GW Pharmaceuticals Business Overview
11.5.3 GW Pharmaceuticals Cannabis Drug Introduction
11.5.4 GW Pharmaceuticals Revenue in Cannabis Drug Business (2019-2024)
11.5.5 GW Pharmaceuticals Recent Development
11.6 Unimed Pharmaceuticals
11.6.1 Unimed Pharmaceuticals Company Detail
11.6.2 Unimed Pharmaceuticals Business Overview
11.6.3 Unimed Pharmaceuticals Cannabis Drug Introduction
11.6.4 Unimed Pharmaceuticals Revenue in Cannabis Drug Business (2019-2024)
11.6.5 Unimed Pharmaceuticals Recent Development
11.7 Indevus Pharmaceuticals
11.7.1 Indevus Pharmaceuticals Company Detail
11.7.2 Indevus Pharmaceuticals Business Overview
11.7.3 Indevus Pharmaceuticals Cannabis Drug Introduction
11.7.4 Indevus Pharmaceuticals Revenue in Cannabis Drug Business (2019-2024)
11.7.5 Indevus Pharmaceuticals Recent Development
11.8 Pharmos
11.8.1 Pharmos Company Detail
11.8.2 Pharmos Business Overview
11.8.3 Pharmos Cannabis Drug Introduction
11.8.4 Pharmos Revenue in Cannabis Drug Business (2019-2024)
11.8.5 Pharmos Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
